Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stabilized liquid and lyophilized ADAMTS13 formulations

Stabilized liquid and lyophilized ADAMTS13 formulations

US Patent 11564979 · Granted Jan 31, 2023

Estimated economic value: $49,364,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS2025
Stabilized liquid and lyophilized ADAMTS13 formulations2024
Stabilized liquid and lyophilized ADAMTS13 formulations2024
Stabilized liquid and lyophilized ADAMTS13 formulations2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
Nucleophilic catalysts for oxime linkage2023
Method to produce a highly concentrated immunoglobulin preparation for subcutane2022
Lyophilized recombinant VWF formulations2021
Lyophilized recombinant VWF formulations2021
Recombinant VWF formulations2021
Recombinant VWF formulations2021
Recombinant VWF formulations2021